Carminati A, Barascut J L, Chenut E, Bourut C, Mathé G, Imbach J L
Laboratoire de Chimie Bio-Organique, UA au CNRS, USTL, France, Montpellier.
Anticancer Drug Des. 1988 Jun;3(1):57-65.
Two series of (2-chloroethyl) nitrosoureas (NICE-NU) bearing a nitroimidazole group have been synthesized for anti-tumor evaluation with the aim of chemopotentiation of their biological activity. Their anti-tumor activity against L1210 in vivo in mice is excellent especially for the series A derivatives where a hydroxy function provides assistance to decomposition. However, the activity of NICE-NU against B16 melanoma is lower.